The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Type I and type II Fc receptors regulate innate and adaptive immunity
Open accessAbstract
Antibodies produced in response to a foreign antigen are characterized by polyclonality, not only in the diverse epitopes to which their variable domains bind but also in the various effector molecules to which their constant regions (Fc domains) engage. Thus, the antibody's Fc domain mediates diverse effector activities by engaging two distinct classes of Fc receptors (type I and type II) on the basis of the two dominant conformational states that the Fc domain may adopt. These conformational states are regulated by the differences among antibody subclasses in their amino acid sequence and by the complex, biantennary Fc-associated N-linked glycan. Here we discuss the diverse downstream proinflammatory, anti-inflammatory and immunomodulatory consequences of the engagement of type I and type II Fc receptors in the context of infectious, autoimmune, and neoplastic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Self-citationInhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationHIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Self-citationObinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Goede, V., Fischer, K., Busch, R., Engelke, A., Eichhorst, B., Wendtner, C. M., Chagorova, T., de la Serna, J., Dilhuydy, M.-S., Illmer, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313984 · Cited by 1,518
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Simpson, T. R., Li, F., Montalvo-Ortiz, W., Sepulveda, M. A., Bergerhoff, K., Arce, F., Roddie, C., Henry, J. Y., Yagita, H., Wolchok, J. D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130579 · Cited by 1,472
Self-citationWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationMusolino, A., Naldi, N., Bortesi, B., Pezzuolo, D., Capelletti, M., Missale, G., Laccabue, D., Zerbini, A., Camisa, R., Bisagni, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8957 · Cited by 981
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 898
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849
Self-citationFerrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Self-citationThe 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
Stuart, L. M., & Ezekowitz, R. A. B. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.002 · Cited by 667
Uchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., & Tedder, T. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040119 · Cited by 642
Self-citationThe function of Fcγ receptors in dendritic cells and macrophages
Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., & Lambrecht, B. N. (2014) · Nature Reviews Immunology · doi:10.1038/nri3582 · Cited by 639
Kliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 578
Identification of a receptor required for the anti-inflammatory activity of IVIG
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 547
Self-citationFcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications
Smith, K. G. C., & Clatworthy, M. R. (2010) · Nature Reviews Immunology · doi:10.1038/nri2762 · Cited by 543
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Self-citationBibeau, F., Lopez-Crapez, E., Di Fiore, F., Thezenas, S., Ychou, M., Blanchard, F., Lamy, A., Penault-Llorca, F., Frébourg, T., Michel, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0463 · Cited by 521
Bulliard, Y., Jolicoeur, R., Windman, M., Rue, S. M., Ettenberg, S., Knee, D. A., Wilson, N. S., Dranoff, G., & Brogdon, J. L. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130573 · Cited by 446
Fc‐Receptors as Regulators of Immunity
Nimmerjahn, F., & Ravetch, J. V. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)96005-8 · Cited by 418
Self-citationActivating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
Boruchov, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24772 · Cited by 377
Kalergis, A. M., & Ravetch, J. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020338 · Cited by 372
Self-citationStructure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
Garman, S. C., Wurzburg, B. A., Tarchevskaya, S. S., Kinet, J.-P., & Jardetzky, T. S. (2000) · Nature · doi:10.1038/35018500 · Cited by 355
Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation
Sutterwala, F. S., Noel, G. J., Clynes, R., & Mosser, D. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1977 · Cited by 351
Dhodapkar, K. M., Krasovsky, J., Williamson, B., & Dhodapkar, M. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011097 · Cited by 349
El Bakkouri, K., Descamps, F., De Filette, M., Smet, A., Festjens, E., Birkett, A., Van Rooijen, N., Verbeek, S., Fiers, W., & Saelens, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0902147 · Cited by 335
Li, F., & Ravetch, J. V. (2011) · Science · doi:10.1126/science.1206954 · Cited by 335
Self-citationThe coordination of signaling during Fc receptor-mediated phagocytosis
Swanson, J. A., & Hoppe, A. D. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804439 · Cited by 331
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs
Anthony, R. M., & Ravetch, J. V. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9405-6 · Cited by 318
Self-citationMouse model recapitulating human Fcγ receptor structural and functional diversity
Smith, P., DiLillo, D. J., Bournazos, S., Li, F., & Ravetch, J. V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203954109 · Cited by 307
Self-citationFcγRIIb controls bone marrow plasma cell persistence and apoptosis
Xiang, Z., Cutler, A. J., Brownlie, R. J., Fairfax, K., Lawlor, K. E., Severinson, E., Walker, E. U., Manz, R. A., Tarlinton, D. M., & Smith, K. G. C. (2007) · Nature Immunology · doi:10.1038/ni1440 · Cited by 296
Antibody‐mediated modulation of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00910.x · Cited by 285
Self-citationvan de Geijn, F. E., Wuhrer, M., Selman, M. H., Willemsen, S. P., de Man, Y. A., Deelder, A. M., Hazes, J. M., & Dolhain, R. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2892 · Cited by 274
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
Monsalvo, A. C., Batalle, J. P., Lopez, M. F., Krause, J. C., Klemenc, J., Hernandez, J. Z., Maskin, B., Bugna, J., Rubinstein, C., Aguilar, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2262 · Cited by 262
Isotype and glycoform selection for antibody therapeutics
Jefferis, R. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.021 · Cited by 252
Wilson, N. S., Yang, B., Yang, A., Loeser, S., Marsters, S., Lawrence, D., Li, Y., Pitti, R., Totpal, K., Yee, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.012 · Cited by 248
Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., & Lünemann, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807319106 · Cited by 242
Dhodapkar, K. M., Kaufman, J. L., Ehlers, M., Banerjee, D. K., Bonvini, E., Koenig, S., Steinman, R. M., Ravetch, J. V., & Dhodapkar, M. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500014102 · Cited by 241
Self-citationVarchetta, S., Gibelli, N., Oliviero, B., Nardini, E., Gennari, R., Gatti, G., Silva, L. S., Villani, L., Tagliabue, E., Ménard, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2068 · Cited by 240
Fc Receptors and Their Role in Immune Regulation and Autoimmunity
Takai, T. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-0353-8 · Cited by 231
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
White, A. L., Chan, H. T. C., Roghanian, A., French, R. R., Mockridge, C. I., Tutt, A. L., Dixon, S. V., Ajona, D., Verbeek, J. S., Al-Shamkhani, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101135 · Cited by 226
Scherer, H. U., van der Woude, D., Ioan‐Facsinay, A., el Bannoudi, H., Trouw, L. A., Wang, J., Häupl, T., Burmester, G., Deelder, A. M., Huizinga, T. W. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27414 · Cited by 223
SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Pearse, R. N., Kawabe, T., Bolland, S., Guinamard, R., Kurosaki, T., & Ravetch, J. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80074-6 · Cited by 219
Self-citationGeneral mechanism for modulating immunoglobulin effector function
Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307864110 · Cited by 218
Self-citationDuerr, A., Huang, Y., Buchbinder, S., Coombs, R. W., Sanchez, J., del Rio, C., Casapia, M., Santiago, S., Gilbert, P., Corey, L., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis342 · Cited by 210
Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4
Chuntharapai, A., Dodge, K., Grimmer, K., Schroeder, K., Marsters, S. A., Koeppen, H., Ashkenazi, A., & Kim, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4891 · Cited by 202
Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S.-C., Scragg, I. G., & Dwek, R. A. (1997) · Biochemistry · doi:10.1021/bi9621472 · Cited by 191
NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic
Barb, A. W., & Prestegard, J. H. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.511 · Cited by 186
Novel roles for the IgG Fc glycan
Anthony, R. M., Wermeling, F., & Ravetch, J. V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06305.x · Cited by 186
Self-citationNimmerjahn, F., & Ravetch, J. V. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_86 · Cited by 180
Self-citationAbnormal glycosylation of serum igg from patients with chronic inflammatory diseases
Tomana, M., Schrohenloher, R. E., Koopman, W. J., Alarcän, G. S., & Paul, W. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310304 · Cited by 177
Albert, H., Collin, M., Dudziak, D., Ravetch, J. V., & Nimmerjahn, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808248105 · Cited by 175
Self-citationInhibitory ITAMs as novel regulators of immunity
Blank, U., Launay, P., Benhamou, M., & Monteiro, R. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00832.x · Cited by 167
Follicular dendritic cells: beyond the necessity of T-cell help
Tew, J. G., Wu, J., Fakher, M., Szakal, A. K., & Qin, D. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01942-1 · Cited by 162
The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice.
Fujiwara, H., Kikutani, H., Suematsu, S., Naka, T., Yoshida, K., Yoshida, K., Tanaka, T., Suemura, M., Matsumoto, N., & Kojima, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6835 · Cited by 161
Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
Borrok, M. J., Jung, S. T., Kang, T. H., Monzingo, A. F., & Georgiou, G. (2012) · ACS Chemical Biology · doi:10.1021/cb300130k · Cited by 158
Functional and clinical consequences of Fc receptor polymorphic and copy number variants
Bournazos, S., Woof, J. M., Hart, S. P., & Dransfield, I. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03980.x · Cited by 157
Self-citationHow Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections
Ubol, S., & Halstead, S. B. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00316-10 · Cited by 151
Barrington, R. A., Pozdnyakova, O., Zafari, M. R., Benjamin, C. D., & Carroll, M. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021110 · Cited by 142
Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination
Selman, M. H. J., de Jong, S. E., Soonawala, D., Kroon, F. P., Adégnika, A. A., Deelder, A. M., Hokke, C. H., Yazdanbakhsh, M., & Wuhrer, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014563 · Cited by 142
T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies
Heß, C., Winkler, A., Lorenz, A. K., Holecska, V., Blanchard, V., Eiglmeier, S., Schoen, A.-L., Bitterling, J., Stoehr, A. D., Petzold, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65938 · Cited by 136
Schwab, I., Mihai, S., Seeling, M., Kasperkiewicz, M., Ludwig, R. J., & Nimmerjahn, F. (2014) · European Journal of Immunology · doi:10.1002/eji.201344230 · Cited by 129
Structural Determinants of Unique Properties of Human IgG4-Fc
Davies, A. M., Rispens, T., Heer, P. O., Gould, H. J., Jefferis, R., Aalberse, R. C., & Sutton, B. J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.039 · Cited by 126
Desai, D. D., Harbers, S. O., Flores, M., Colonna, L., Downie, M. P., Bergtold, A., Jung, S., & Clynes, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6217 · Cited by 122
Crow, A. R., Song, S. M., Freedman, J. J., Helgason, C. D., Humphries, R. K., Siminovitch, K. A., & Lazarus, A. H. (2003) · Blood · doi:10.1182/blood-2003-01-0023 · Cited by 119
Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
Schuurhuis, D. H., van Montfoort, N., Ioan‐Facsinay, A., Jiawan-Lalai, R., Camps, M. G. M., Nouta, J., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4573 · Cited by 119
Li, F., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319502110 · Cited by 115
Self-citationCrow, A. R., Song, S. M., Semple, J. W., Freedman, J. J., & Lazarus, A. H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03136.x · Cited by 115
IVI g‐mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR 1
Schwab, I., Biburger, M., Krönke, G., Schett, G. A., & Nimmerjahn, F. (2012) · European Journal of Immunology · doi:10.1002/eji.201142260 · Cited by 113
A requirement for FcγR in antibody-mediated bacterial toxin neutralization
Abboud, N., Chow, S.-K., Saylor, C., Markmann, A. J., Ravetch, J. V., Scharff, M. D., & Casadevall, A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100995 · Cited by 109
Self-citationTolerance induction with T cell–dependent protein antigens induces regulatory sialylated IgGs
Oefner, C. M., Winkler, A., Heß, C., Lorenz, A. K., Holecska, V., Huxdorf, M., Schommartz, T., Petzold, D., Bitterling, J., Schoen, A.-L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.037 · Cited by 108
Xu, Y., Szalai, A. J., Zhou, T., Zinn, K. R., Chaudhuri, T. R., Li, X., Koopman, W. J., & Kimberly, R. P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.562 · Cited by 108
Espy, C., Morelle, W., Kavian, N., Grange, P., Goulvestre, C., Viallon, V., Chéreau, C., Pagnoux, C., Michalski, J., Guillevin, L., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30362 · Cited by 108
Dhaliwal, B., Yuan, D., Pang, M. O. Y., Henry, A. J., Cain, K., Oxbrow, A., Fabiane, S. M., Beavil, A. J., McDonnell, J. M., Gould, H. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207278109 · Cited by 94
Impact of Differential Glycosylation on IgG Activity
Lux, A., & Nimmerjahn, F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_10 · Cited by 91
Gonzalez, D. C., Castro, O., Kourí, G., Pérez, J., Martinez, E., Vázquez, S., Rosario, D., Cancio, R., & Guzmán, M. G. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.012 · Cited by 90
Chapter 5 Human B Cell Subsets
Jackson, S. M., Wilson, P. C., James, J. A., & Capra, J. D. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00405-7 · Cited by 88
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
Crow, A. R., Song, S. M., Semple, J. W., Freedman, J. J., & Lazarus, A. H. (2006) · Blood · doi:10.1182/blood-2006-05-023796 · Cited by 87
Shinzaki, S., Iijima, H., Nakagawa, T., Egawa, S., Nakajima, S., Ishii, S., Irie, T., Kakiuchi, Y., Nishida, T., Yasumaru, M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01699.x · Cited by 84
IgG2 Fc structure and the dynamic features of the IgG CH2–CH3 interface
Teplyakov, A., Zhao, Y., Malia, T., Obmolova, G., & Gilliland, G. L. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.03.018 · Cited by 77
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
Bournazos, S., Chow, S.-K., Abboud, N., Casadevall, A., & Ravetch, J. V. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72676 · Cited by 66
Self-citationTedder, T. F., Baras, A., & Xiu, Y. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0057-9 · Cited by 62
Antibody-Enhanced Infection of Monocytes as the Pathogenetic Mechanism for Severe Dengue Illness
Kliks, S. C. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.993 · Cited by 60
Analysis of the antibody structure based on high-resolution crystallographic studies
Narciso, J. E. T., Uy, I. D., Cabang, A. B., Chavez, J. F. C., Pablo, J. L., Padilla-Concepcion, G., & PADLAN, E. A. (2011) · New Biotechnology · doi:10.1016/j.nbt.2011.03.012 · Cited by 44
A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies
Li, F., & Ravetch, J. V. (2012) · Cell Cycle · doi:10.4161/cc.21842 · Cited by 34
Self-citationIgG2a‐Mediated Enhancement of Antibody Responses is dependent on FcRγ+ Bone Marrow‐Derived Cells
de Ståhl, T. D., & Heyman, B. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.01000.x · Cited by 32
Guihot, A., Luyt, C. E., Parrot, A., Rousset, D., Cavaillon, J., Boutolleau, D., Fitting, C., Pajanirassa, P., Mallet, A., Fartoukh, M. S., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-2071oc · Cited by 31
Killing some to make way for others
Ravetch, J. V., & Nussenzweig, M. C. (2007) · Nature Immunology · doi:10.1038/ni0407-337 · Cited by 25
Self-citationDiversity and Duplicity: Human Fcγ Receptors in Host Defense and Autoimmunity
Kimberly, R. P., Wu, J., Gibson, A., Su, K., Qin, H., Li, X., & Edberg, J. C. (2002) · Immunologic Research · doi:10.1385/ir:26:1-3:177 · Cited by 23
Basis of the Intrinsic Flexibility of the Cε3 Domain of IgE
Borthakur, S., Andrejeva, G., & McDonnell, J. M. (2011) · Biochemistry · doi:10.1021/bi200019y · Cited by 22
Ravetch, J. V., & Carroll, M. C. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50019-8 · Cited by 1
Self-citation
Cited by
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
The multiple pathways to autoimmunity
Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M., Yu, W. H., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C., Leung, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 571
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Bournazos, S., Klein, F., Pietzsch, J., Seaman, M. S., Nussenzweig, M. C., & Ravetch, J. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.023 · Cited by 493
Self-citation
Metadata
- Authors
- Pincetic, A., Bournazos, S., DiLillo, D. J., Maamary, J., Wang, T. T., Dahan, R., Fiebiger, B.-M., & Ravetch, J. V.
- Venue
- Nature Immunology
- Published
- 2014-07-21
- Volume
- 15
- Issue
- 8
- Pages
- 707-716
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2116661011
- Cited by
- 514
- References
- 104
- FWCI
- 33.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.